Does Mounjaro Make You Poop More? (October 2026)

01 · The core answer

So, does Mounjaro make you poop more?

For some people, yes. Mounjaro is the brand name for tirzepatide, a once-weekly injection licensed in the UK for weight management and type 2 diabetes¹. It activates two gut-hormone receptors, GIP and GLP-1, and one of the effects is slower stomach emptying¹. A medicine that changes the pace of your digestion can plausibly change what happens further down the gut.

The effect is not the same for everyone. Some people find their stools looser or more frequent. Others find the opposite, with slower or harder-to-pass stools. Others notice no difference. Feeling sick, diarrhoea, being sick, stomach pain and constipation are all very common, affecting more than 1 in 10 people¹³.

The same applies to other GLP-1 medicines. If you are asking about Ozempic, Wegovy or any other GLP-1 treatment, each has its own product information, and the Wegovy one is published on the emc¹⁸. Ozempic is semaglutide licensed for type 2 diabetes only; it is not a UK weight-loss medicine. Our wider guide on whether GLP-1 medicines make you poop covers the class more broadly.

02 · Your next step

What should you do if your bowels change?

First, note the pattern. Write down when the change began, whether it followed your first injection or a move to a higher strength, and whether it settles from week to week. That record is genuinely useful to a prescriber.

Second, read the side-effect section of your leaflet¹³. It tells you which symptoms are listed and which need prompt medical attention. If your symptoms are not listed, say so when you talk to your prescriber.

Third, speak to the prescribing team before changing anything yourself. Do not skip doses or alter your strength on your own. If you are already a customer, our monthly reviews and side-effect support exist for exactly this.

Get medical help straight away if you have severe, persistent stomach pain, pain in the upper right abdomen, fever, yellowing of the skin or eyes, or signs of a severe allergic reaction. If you cannot keep fluids down, contact your clinical team, as dehydration needs medical help straight away. Do not wait for your next review in those situations.

03 · A common misreading

Is pooping more a sign the medicine is working?

No. Stool frequency is not how Mounjaro's effect is measured. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone². Those are trial averages, and individual results vary. The outcome was body weight, not bowel movements.

So more trips to the bathroom do not mean you are losing more weight, and fewer do not mean the medicine is failing. Treat bowel changes as a side effect to manage, not as a progress indicator.

04 · Why digestion changes

Why Mounjaro can change your digestion

The reason lies in the mechanism. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin¹.

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet¹. That fullness comes partly from food leaving the stomach more slowly. Digestion is a connected system, so a change at the top of it does not stay neatly at the top.

Two things follow from this. First, you would expect your eating pattern to alter, because you are eating less and often smaller portions. A smaller, different intake changes what reaches the bowel, whatever the medicine is doing directly. Second, you would expect individual variation. Gut hormones interact with your diet, your usual bowel habit, other medicines and any digestive conditions you already have, so two people on the same strength can have different experiences.

This also explains why the answer is not simply yes or no. Mounjaro does not have a single predictable effect on stools. It shifts the conditions in which your gut works, and the result is individual. If you want a plain-language summary of the same question, our related guide on whether Mounjaro makes you poop sets out the basics, and the guide to pooping a lot covers the more frequent end of the range.

Finally, remember that a medicine can be working as designed and still cause an unwanted effect. Slowed stomach emptying is part of how Mounjaro supports reduced eating. That same action can be the source of the digestive effects some people report. That is a trade-off to discuss with your prescriber, not a reason to stop abruptly.

05 · Both directions of change

Looser stools, constipation, or no change

Bowel changes on Mounjaro do not all point the same way. Because the medicine slows stomach emptying and alters gut function¹, some people find their stools looser or more frequent, and others find them slower and harder. A third group notices very little. All three are plausible with the same medicine, and none is a sign you are doing something wrong.

That matters for how you read your own experience. If you have been told online that Mounjaro "always" makes you poop more, or that it "always" causes constipation, neither claim is reliable. What matters is your pattern, your comfort, and whether it is changing in a way that worries you.

A few practical questions help you work out which direction you are in and what to tell a clinician:

• Are you going more often than your normal, or less often?
• Are stools looser than usual, or harder and more difficult to pass?
• Did it start soon after your first injection, or after moving up a strength?
• Is it improving, staying the same, or getting worse?
• Are there other symptoms alongside it, such as stomach discomfort or nausea?

They simply make the conversation faster and more useful.

The patient information leaflet lists the side effects associated with the medicine¹³. If something you are experiencing is not on the leaflet list, it is not a listed side effect. It means it is worth raising with your prescriber, and reporting through the Yellow Card scheme if you suspect it is linked to the medicine¹⁹.

Colour changes have their own explanation, and we cover them separately in our guide on whether Mounjaro can make your poop green. Appearance alone is rarely the whole story, so describe it to a clinician if it persists or concerns you.

The takeaway is simple. Expect individual variation, observe your own pattern, and let a prescriber decide whether it needs any change to your plan. Do not assume a particular direction in advance, and do not self-adjust your treatment based on what someone else reported.

06 · Timing and dose steps

When bowel changes tend to show up

The most useful clue is timing. Mounjaro is started at a low strength and stepped up. The dose changes after at least four weeks on each dose, depending on how you respond.

Because your body meets a new level of the medicine at each step, it is sensible to watch the period after each change. If your bowels are different after a step up, that timing is worth noting. If they were unchanged on 2.5mg but shifted on 5mg, say so. Tell your prescriber exactly which strength you were on and when you moved.

The first few weeks are the period when your body is adjusting to a new medicine, and also when your eating pattern is changing most. Both can affect your bowels, so it can be hard to say which is responsible. That is another reason a prescriber's view is worth having rather than guessing.

If you have a late injection, a changed routine, or travel, note that too. Disrupted eating and drinking can affect bowel habit independently of any medicine.

Our service reviews your progress and handles dose titration through ongoing monthly reviews, and repeat orders re-check suitability. Nothing ships automatically. That structure exists so a bowel change gets looked at before your next pen, not after.

If a symptom is troubling you at your current strength, the right move is a conversation with your prescriber, who can decide on the safest way forward.

07 · Poop and weight loss myths

Does pooping more mean you are losing weight or fat?

Pooping more does not tell you that you are losing weight, and it does not mean you are "pooping out fat". Weight loss on Mounjaro is judged by changes in body weight over time, not by bathroom frequency.

The trial evidence reflects that. In SURMOUNT-1, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone². These are trial averages and individual results vary. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them².

As a worked example, for someone starting at 100 kg, 20.9% is about 21 kg. That figure is straight arithmetic from the trial average, not a prediction for you.

There is also a risk in treating loose stools as a good sign. If you are going more often and feeling unwell, that is a symptom to report, not progress. Equally, if your bowels are slower, it does not mean the medicine is not working.

If you want a simple way to follow your journey, our free GLPTrackr companion app is designed for tracking a GLP-1 journey on iOS and Android. It lets you record injections and how you feel in one place, which also helps if you later need to describe symptoms to a prescriber.

In short, use your weight trend to judge results, and use your bowel pattern to judge tolerability. They answer different questions.

08 · Other GLP-1 medicines

What about Ozempic, Wegovy and other GLP-1 medicines?

People often ask the same question about Ozempic, Wegovy and the wider GLP-1 class, and the honest answer is to check each product's own information. GLP-1 medicines share some mechanism, since GLP-1 activity is involved in slowing how quickly the stomach empties¹. But the products are different medicines with different leaflets.

Wegovy is semaglutide, a single-action GLP-1 medicine, whereas Mounjaro activates both GIP and GLP-1 receptors¹. The Wegovy pens run from 0.25mg through 0.5mg, 1mg and 1.7mg to the 2.4mg maintenance dose, stepping up after at least four weeks and reaching 2.4mg from week 17. Its side effects are set out in its own product characteristics¹⁸.

If you are comparing the two for tolerability, do not rely on a single headline. Read both documents, and speak to a prescriber about your own history, including any existing bowel conditions.

For general questions about how the class behaves, see our guide to whether GLP-1 medicines make you poop.

09 · When to get help

When to speak to a clinician about bowel changes

Speak to a clinician when a bowel change is persistent, severe, getting worse, or accompanied by other symptoms that worry you. The patient information leaflet identifies which side effects need prompt medical attention¹³, so keep it to hand and read that section before you need it.

Use these routes depending on how urgent it feels:

• Urgent or severe symptoms: get medical help straight away, and call 999 or go to A&E if you feel seriously unwell.
• Ongoing but not urgent: contact the prescribing team that supplies your treatment and describe the pattern you have recorded.
• Unsure whether it is related: ask your pharmacist or prescriber, especially if you take other medicines.

If you suspect a side effect is linked to Mounjaro, you can report it through the MHRA Yellow Card scheme¹⁹. Reports help the regulator monitor medicines, and you can submit one yourself without waiting for a clinician.

If you are an EverydayMeds customer, our support team is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat, or by phone on 0333 207 0413. Ongoing monthly reviews, dose titration and side-effect support are part of the service, and every repeat order re-checks suitability.

Tell the prescriber about anything else relevant: other medicines, existing digestive conditions, recent illness and changes in eating or drinking. Mounjaro is a prescription-only medicine, supplied after a consultation reviewed by a GPhC-registered prescriber¹, and is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.

Do not stop, skip or change your dose on your own because of a bowel symptom without talking to a clinician first. If you do stop, tirzepatide has a half-life of about five days, so it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears¹. That means any effects from the medicine may not disappear immediately.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · Getting treatment safely

NHS or private: how to get Mounjaro safely

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions⁴. Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting. The weight loss clinic page explains the options.

If you choose private treatment, how and where you buy matters. Mounjaro should only be supplied after a consultation and prescription. Be wary of any seller offering to supply without a consultation or prescription, and of medicine offered at suspiciously low prices. The MHRA publishes counterfeit alerts and runs the Yellow Card scheme⁷. You can check any pharmacy on the GPhC register, and ours is GPhC 9012878.

• Free online consultation: a short health questionnaire, with no charge and no obligation.
• Prescriber review: reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Dispensing and delivery: dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm and free next-day tracked delivery in temperature-controlled packaging. Saturday delivery is £14.99.

We supply genuine KwikPens through official LillyDirect supply, direct from Eli Lilly's UK distribution. Needles, a sharps bin and injection guidance come with every order. The price shown is the price paid, with no hidden fees.

You may also be wondering about other effects people ask about, such as whether it changes how often you urinate or affects mood and irritability. Each has its own guide.